Perspectives

Perspectives

Commentary and highlights from contributors and readers

How would you manage a patient who meets morphologic, but not molecular, criteria for...

Here’s how readers responded to a You Make the Call question about a patient with a morphologic presentation suggestive of acute promyelocytic leukemia (APL),...

What’s in a (Drug) Name?

Shakespeare claimed that a rose by any other name would smell as sweet. A medication with a confusing name, though, can cause a fatal...

Strengthening the Role of the Oncology Nurse Practitioner

In this edition, Catherine Bishop, DNP, NP, introduces a series of articles about issues affecting oncology nurse practitioners. Here, Dr. Bishop describes how these...

Updates to Our Style Guide for the Sartorially Challenged

Every so often, the crackerjack editorial team of ASH Clinical News gets together and discusses style. No, not of the sartorial variety, particularly as mine...

How would you treat a patient with the C282Y mutation and a family history...

Here’s how readers responded to a You Make the Call question about managing a patient with the C282Y mutation and a family history of...
Alice Ma, MD

Not What I Signed up For

Last month, while at a mandatory conference at our hospital and idly checking my email, a note from my nurse caught my attention: “Dr....
Dr. Yang (coach of the Ice Station Stars) and his son celebrate a recent win.

From the Ivory Tower to Corporate America

When I started in the MD/PhD program at a prestigious university in southern California, I was a 22-year-old straight out of college with few...

What are the treatment options for a pregnant woman with chronic-phase CML?

Here’s how readers responded to a You Make the Call question about managing a pregnant patient with chronic-phase (CP) chronic myeloid leukemia (CML). Disclaimer: ASH does...

The Good Steward of Science

I have participated in a number of clinical trials and database projects with pharmaceutical companies and, as a result, have been an author on...

How would you manage VTE risk in a transgender patient who needs hormone replacement...

Here’s how readers responded to a You Make the Call question about venous thromboembolism (VTE) risk in a transgender patient who needs hormone replacement...
Advertisement

Current Issue

October 2018, Volume 4, Issue 12

This issue features a look at the Right to Try debate, a breakdown of how epigenetics are used in hematology, and more.